Table 3  New products in development for treatment of ADHD in children and adolescents: overview of compounds not yet available in England and Germany  Only projects in phase III of clinical development or products already marketed in the United States. DaytranaR was formerly known as "MethypatchR", SparlonR as "AttenaceR". Data source: InnoVal-HC, 2006 [49].